wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q34198692-CE8C1415-47DF-466A-AE5D-229DDC8F5591
Q34198692-CE8C1415-47DF-466A-AE5D-229DDC8F5591
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34198692-CE8C1415-47DF-466A-AE5D-229DDC8F5591
Update on developments with SGLT2 inhibitors in the management of type 2 diabetes
P2860
Q34198692-CE8C1415-47DF-466A-AE5D-229DDC8F5591
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34198692-CE8C1415-47DF-466A-AE5D-229DDC8F5591
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f0919e0859eaec45923326d209f28c0022d92c6b
P2860
Empagliflozin as add-on to metformin plus sulfonylurea in patients with type 2 diabetes: a 24-week, randomized, double-blind, placebo-controlled trial